Dialyzer Performance During Hemodialysis Without Systemic Anticoagulation Using a Heparin-Grafted Dialyzer Combined With a Citrate-Enriched Dialysate: Results of the Randomized Crossover Noninferiority EvoCit Study
American Journal of Kidney Diseases（2022）
摘要
Evocit is non-inferior to Evohep with respect to solute clearance but results in a greater number of shortened treatments, more membrane clotting and greater thrombin generation.
更多查看译文
关键词
Anticoagulation,bleeding risk,blood compartment volume,clotting,dialysis adequacy,dialysis dose,end-stage renal disease (ESRD),extracorporeal circuit,heparin-free hemodialysis,noninferiority trial,randomized crossover study,systemic anticoagulation,thrombin generation,treatment length
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要